Phase IISmall Molecule
Compound 61567
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061567
Risk Class
MODERATE
Last Audit
Apr 13, 2108
Research Abstract
Small Molecule candidate engineered for endocrine support initiatives with automated dossier coverage.
Compound 61567 is a small molecule asset inside small molecule innovation track initiatives, optimized for endocrine support and performance longevity.
The dossier currently sits in phase ii with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.
Supply records cite CAS AUTO-061567 with updates logged 2108-04-13.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Endocrine supportPerformance longevity
Nomenclature
CX-61567Small Molecule Program 61567
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061567
- [2] Operations Pulse • Small Molecule innovation track
- [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61567